PubMed · 12555025
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Ken Miller. 2003. Two Firsts for ORS.. https://doi.org/10.1097/00004032-200302001-00001
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Precision oncology relies on integrating tumour fraction, variant allele frequency, clonal haematopoiesis of indeterminate potential assessment, pathogenicity, and clinical context into next-generation sequencing interpretation, enabling biologically informed and clinically meaningful treatment decisions while reducing the risk of overinterpreting nontumour or nonactionable genomic alterations.